Search

Your search keyword '"Ellington, Sascha"' showing total 753 results
Start Over Author "Ellington, Sascha"
753 results on '"Ellington, Sascha"'

2. Assessment and mitigation of bias in influenza and COVID-19 vaccine effectiveness analyses — IVY Network, September 1, 2022–March 30, 2023

Author

Lewis, Nathaniel M., Harker, Elizabeth J., Leis, Aleda, Zhu, Yuwei, Talbot, H. Keipp, Grijalva, Carlos G., Halasa, Natasha, Chappell, James D., Johnson, Cassandra A., Rice, Todd W., Casey, Jonathan D., Lauring, Adam S., Gaglani, Manjusha, Ghamande, Shekhar, Columbus, Cristie, Steingrub, Jay S., Shapiro, Nathan I., Duggal, Abhijit, Felzer, Jamie, Prekker, Matthew E., Peltan, Ithan D., Brown, Samuel M., Hager, David N., Gong, Michelle N., Mohamed, Amira, Exline, Matthew C., Khan, Akram, Wilson, Jennifer G., Mosier, Jarrod, Qadir, Nida, Chang, Steven Y., Ginde, Adit A., Mohr, Nicholas M., Mallow, Christopher, Harris, Estelle S., Johnson, Nicholas J., Srinivasan, Vasisht, Gibbs, Kevin W., Kwon, Jennie H., Vaughn, Ivana A., Ramesh, Mayur, Safdar, Basmah, DeCuir, Jennifer, Surie, Diya, Dawood, Fatimah S., Ellington, Sascha, Self, Wesley H., and Martin, Emily T.

Published
2025
Full Text
View/download PDF

3. Underutilization of Influenza Antiviral Treatment Among Children and Adolescents at Higher Risk for Influenza-Associated Complications--United States, 2023-2024

Author

Frutos, Aaron M., Ahmad, Haris M., Ujamaa, Dawud, O'Halloran, Alissa C., Englund, Janet A., Klein, Eileen J., Zerr, Danielle M., Crossland, Melanie, Staten, Holly, Boom, Julie A., Sahni, Leila C., Halasa, Natasha B., Stewart, Laura S., Hamdan, Olla, Stopczynski, Tess, Schaffner, William, Talbot, H. Keipp, Michaels, Marian G., Williams, John V., Sutton, Melissa, Hendrick, M. Andraya, Staat, Mary A., Schlaudecker, Elizabeth P., Tesini, Brenda L., Felsen, Christina B., Weinberg, Geoffrey A., Szilagyi, Peter G., Anderson, Bridget J., Rowlands, Jemma V., Khalifa, Murtada, Martinez, Marc, Selvarangan, Rangaraj, Schuster, Jennifer E., Lynfield, Ruth, McMahon, Melissa, Kim, Sue, Nunez, Val Tellez, Ryan, Patricia A., Monroe, Maya L., Wang, Yun F., Openo, Kyle P., Meek, James, Yousey-Hindes, Kimberly, Alden, Nisha B., Armistead, Isaac, Rao, Suchitra, Chai, Shua J., Kirley, Pam Daily, Toepfer, Ariana P., Dawood, Fatimah S., Moline, Heidi L., Uyeki, Timothy M., Ellington, Sascha, Garg, Shikha, Bozio, Catherine H., and Olson, Samantha M.

Subjects
Merck & Company Inc., Pfizer Inc., Vaccination, Influenza viruses, Influenza vaccines -- Complications and side effects, Influenza -- Complications and side effects -- Drug therapy, Hospital patients -- Drug therapy, Health
Abstract

Introduction Annually, seasonal influenza virus infections among children and adolescents in the United States are estimated to result in millions of medical visits, tens of thousands of hospitalizations, and hundreds [...]

Published
2024

4. Serologic Evidence of Recent Infection with Highly Pathogenic Avian Influenza A(H5) Virus Among Dairy Workers--Michigan and Colorado, June-August 2024

Author

Mellis, Alexandra M., Coyle, Joseph, Marshall, Kristen E., Frutos, Aaron M., Singleton, Jordan, Drehoff, Cara, Merced-Morales, Angiezel, Pagano, H. Pamela, Alade, Rachel O., White, Elizabeth B., Noble, Emma K., Holiday, Crystal, Liu, Feng, Jefferson, Stacie, Li, Zhu-Nan, Gross, F. Liani, Olsen, Sonja J., Dugan, Vivien G., Reed, Carrie, Ellington, Sascha, Montoya, Sophia, Kohnen, Allison, Stringer, Ginger, Alden, Nisha, Blank, Peter, Chia, Derick, Bagdasarian, Natasha, Herlihy, Rachel, Lyon-Callo, Sarah, and Levine, Min Z.

Subjects
United States. Department of Health and Human Services, Social service, Avian influenza -- Prevention -- Development and progression, Dairy cattle, Dairy farming, Prevalence studies (Epidemiology), Infection -- Development and progression -- Prevention, Disease transmission -- Prevention -- Development and progression, Public health, Health
Abstract

Introduction Highly pathogenic avian influenza (HPAI) A(H5) viruses have been circulating among animals worldwide since 1997, with sporadic human infections, primarily associated with exposure to infected poultry. * In March [...]

Published
2024

5. Personal Protective Equipment Use by Dairy Farmworkers Exposed to Cows Infected with Highly Pathogenic Avian Influenza A(H5N1) Viruses--Colorado, 2024

Author

Marshall, Kristen E., Drehoff, Cara C., Alden, Nisha, Montoya, Sophia, Stringer, Ginger, Kohnen, Allison, Mellis, Alexandra, Ellington, Sascha, Singleton, Jordan, Reed, Carrie, and Herlihy, Rachel

Subjects
United States. Department of Agriculture, United States. Department of Health and Human Services, Protective clothing, Avian influenza viruses, Dairy cattle, Dairy farming, Influenza, Public health, Health
Abstract

Investigation and Results Background On April 25, 2024, Colorado detected highly pathogenic avian influenza (HPAI) A(H5N1) virus in cows on a dairy farm. During April-August 2024, an additional 63 dairy [...]

Published
2024

8. Emergency Preparedness in Tennessee Women with a Recent Live Birth

Author

Miller, Angela M., Galang, Romeo R., Hall, Lindsey E., Strid, Penelope, Leverett, Uvonne, and Ellington, Sascha R.

Subjects
Health care industry
Abstract

Objectives To assess emergency preparedness (EP) actions in women with a recent live birth. Methods Weighted survey procedures were used to evaluate EP actions taken by women with a recent live birth responding to an EP question assessing eight preparedness actions as part of the 2016 Tennessee Pregnancy Risk Assessment and Monitoring System (PRAMS) survey. Factor analysis was used to group preparedness actions. Results Overall, 82.7% [95% Confidence Interval (CI) 79.3%, 86.1%] of respondents reported any preparedness actions, with 51.8% (95% CI 47.2%, 56.4%) completing 1-4 actions. The most common actions were having supplies at home (63.0%; 95% CI 58.5%, 67.4%), an evacuation plan for children (48.5%; 95% CI 43.9%, 53.2%), supplies in another location (40.2%; 95% CI 35.6%, 44.7%), and a communication plan (39.7%; 95% CI 35.1%, 44.2%). Having personal evacuation plans (31.6%; 95% CI 27.3%, 36.0%) and copies of documents in alternate locations (29.3%; 95% CI 25.0%, 33.5%) were least common. Factor analysis yielded three factors: having plans, having copies of documents, and having supplies. Specific preparedness actions varied by education and income level. Conclusions for Practice Most Tennessee women (about 8 in 10 women) with a recent live birth reported at least one EP action. A three-part EP question may be sufficient for assessing preparedness in this population. These findings highlight opportunities to improve public health education efforts around EP., Author(s): Angela M. Miller [sup.1] , Romeo R. Galang [sup.2] , Lindsey E. Hall [sup.1] , Penelope Strid [sup.2] , Uvonne Leverett [sup.1] , Sascha R. Ellington [sup.2] Author Affiliations: [...]

Published
2023
Full Text
View/download PDF

9. SARS-CoV-2 infection, inflammation and birth outcomes in a prospective NYC pregnancy cohort

Author

Gigase, Frederieke A.J., Jessel, Rebecca H., Kaplowitz, Elianna, Boychuk, Natalie, Ohrn, Sophie, Ibroci, Erona, I, Castro, Juliana, Lynch, Jezelle, Tubassum, Rushna, Balbierz, Amy, Molenaar, Nina M., Graziani, Mara, Missall, Roy, Flores, Tammy, Stern, Toni, Carreno, Juan Manuel, Krammer, Florian, Adler, Alan, Brody, Rachel I., Lesseur, Corina, Chen, Jia, Ellington, Sascha, Galang, Romeo R., Snead, Margaret C., Howell, Elizabeth, Stone, Joanne, Bergink, Veerle, Dolan, Siobhan, Lieb, Whitney, Rommel, Anna-Sophie, de Witte, Lotje D., and Janevic, Teresa

Published
2024
Full Text
View/download PDF

10. Pregnancy and infant outcomes following SARS-CoV-2 infection in pregnancy during delta variant predominance – Surveillance for Emerging Threats to Pregnant People and Infants

Author

Reeves, Emily L., Neelam, Varsha, Carlson, Jeffrey M., Olsen, Emily O., Fox, Charise J., Woodworth, Kate R., Nestoridi, Eirini, Mobley, Evan, Montero Castro, Shaila, Dzimira, Paula, Sokale, Ayomide, Sizemore, Lindsey, Hall, Aron J., Ellington, Sascha, Cohn, Amanda, Gilboa, Suzanne M., and Tong, Van T.

Published
2024
Full Text
View/download PDF

11. Cluster of Influenza A(H5) Cases Associated with Poultry Exposure at Two Facilities--Colorado, July 2024

Author

Drehoff, Cara C., White, Elizabeth B., Frutos, Aaron M., Stringer, Ginger, Burakoff, Alexis, Comstock, Nicole, Cronquist, Alicia, Alden, Nisha, Armistead, Isaac, Kohnen, Allison, Ratnabalasuriar, Radhika, Travanty, Emily A., Matzinger, Shannon R., Rossheim, Alexandria, Wellbrock, Aleigha, Pagano, H. Pamela, Wang, Dennis, Singleton, Jordan, Sutter, Rebekah A., Davis, C. Todd, Kniss, Krista, Ellington, Sascha, Kirby, Marie K., Reed, Carrie, and Herlihy, Rachel

Subjects
Colorado. Department of Public Health and Environment, Avian influenza, Medical research, Medicine, Experimental, Euthanasia, Avian influenza viruses, Dairy cattle, Conjunctivitis, Poultry industry, Infection, Public health, Health
Abstract

Investigation and Results Public Health Notification and Response On July 8, 2024, poultry in a commercial egg-layer operation in northeast Colorado (facility A) * were confirmed to have highly pathogenic [...]

Published
2024

16. Characteristics and treatment of hospitalized pregnant women with COVID-19

Author

Sekkarie, Ahlia, Woodruff, Rebecca, Whitaker, Michael, Kramer, Michael R., Zapata, Lauren B., Ellington, Sascha R., Meaney-Delman, Dana M., Pham, Huong, Patel, Kadam, Taylor, Christopher A., Chai, Shua J., Kawasaki, Breanna, Meek, James, Openo, Kyle P., Weigel, Andy, Leegwater, Lauren, Como-Sabetti, Kathryn, Ropp, Susan L., Muse, Alison, Bennett, Nancy M., Billing, Laurie M., Sutton, Melissa, Talbot, H. Keipp, Hill, Mary, and Havers, Fiona P.

Published
2022
Full Text
View/download PDF

17. Pulmonary and Critical Care Considerations for e-Cigarette, or Vaping, Product Use-Associated Lung Injury

Author

Hayes, Don, Jr., Board, Amy, Calfee, Carolyn S., Ellington, Sascha, Pollack, Lori A., Kathuria, Hasmeena, Eakin, Michelle N., Weissman, David N., Callahan, Sean J., Esper, Annette M., Crotty Alexander, Laura E., Sharma, Nirmal S., Meyer, Nuala J., Smith, Lincoln S., Novosad, Shannon, Evans, Mary E., Goodman, Alyson B., Click, Eleanor S., Robinson, Richard T., Ewart, Gary, and Twentyman, Evelyn

Published
2022
Full Text
View/download PDF

20. Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged [greater than or equal to]18 Years--VISION and IVY Networks, September 2023- January 2024

Author

DeCuir, Jennifer, Payne, Amanda B., Self, Wesley H., Rowley, Elizabeth A.K., Dascomb, Kristin, DeSilva, Malini B., Irving, Stephanie A., Grannis, Shaun J., Ong, Toan C., Klein, Nicola P., Weber, Zachary A., Reese, Sarah E., Ball, Sarah W., Barron, Michelle A., Naleway, Allison L., Dixon, Brian E., Essien, Inih, Bride, Daniel, Natarajan, Karthik, Fireman, Bruce, Shah, Ami B., Okwuazi, Erica, Wiegand, Ryan, Zhu, Yuwei, Lauring, Adam S., Martin, Emily T., Gaglani, Manjusha, Peltan, Ithan D., Brown, Samuel M., Ginde, Adit A., Mohr, Nicholas M., Gibbs, Kevin W., Hager, David N., Prekker, Matthew, Mohamed, Amira, Srinivasan, Vasisht, Steingrub, Jay S., Khan, Akram, Busse, Laurence W., Duggal, Abhijit, Wilson, Jennifer G., Chang, Steven Y., Mallow, Christopher, Kwon, Jennie H., Exline, Matthew C., Columbus, Cristie, Vaughn, Ivana A., Safdar, Basmah, Mosier, Jarrod M., Harris, Estelle S., Casey, Jonathan D., Chappell, James D., Grijalva, Carlos G., Swan, Sydney A., Johnson, Cassandra, Lewis, Nathaniel M., Ellington, Sascha, Adams, Katherine, Tenforde, Mark W., Paden, Clinton R., Dawood, Fatimah S., Fleming-Dutra, Katherine E., Surie, Diya, and Link-Gelles, Ruth

Subjects
Vaccination, Medical research, Medicine, Experimental, Hospitals -- Emergency service, Emergency medicine, Adults, Vaccines, Health, Vanderbilt University. Medical Center
Abstract

Introduction On September 12, 2023, CDC's Advisory Committee on Immunization Practices recommended updated 2023-2024 COVID-19 vaccination with a monovalent XBB.1.5--derived vaccine for all persons aged [greater than or equal to]6 [...]

Published
2024

21. Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness--United States

Author

Frutos, Aaron M., Price, Ashley M., Harker, Elizabeth, Reeves, Emily L., Ahmad, Haris M., Murugan, Vel, Martin, Emily T., House, Stacey, Saade, Elie A., Zimmerman, Richard K., Gaglani, Manjusha, Wernli, Karen J., Walter, Emmanuel B., Michaels, Marian G., Staat, Mary A., Weinberg, Geoffrey A., Selvarangan, Rangaraj, Boom, Julie A., Klein, Eileen J., Halasa, Natasha B., Ginde, Adit A., Gibbs, Kevin W., Zhu, Yuwei, Self, Wesley H., Tartof, Sara Y., Klein, Nicola P., Dascomb, Kristin, DeSilva, Malini B., Weber, Zachary A., Yang, Duck-Hye, Ball, Sarah W., Surie, Diya, DeCuir, Jennifer, Dawood, Fatimah S., Moline, Heidi L., Toepfer, Ariana P., Clopper, Benjamin R., Link-Gelles, Ruth, Payne, Amanda B., Chung, Jessie R., Flannery, Brendan, Lewis, Nathaniel M., Olson, Samantha M., Adams, Katherine, Tenforde, Mark W., Garg, Shikha, Grohskopf, Lisa A., Reed, Carrie, and Ellington, Sascha

Subjects
United States. National Institutes of Health, Merck & Company Inc., Pfizer Inc., Vaccination -- Health aspects, Medical research -- Health aspects, Medicine, Experimental -- Health aspects, Influenza vaccines -- Health aspects, Influenza -- Health aspects, Medical colleges -- Health aspects, Children -- Health aspects, Health, Vanderbilt University. Medical Center
Abstract

Introduction CDC's Advisory Committee on Immunization Practices recommends annual influenza vaccination for all persons aged [greater than or equal to]6 months (1). During previous influenza seasons, influenza vaccination prevented hundreds [...]

Published
2024

22. Preventing Influenza Virus Infection and Severe Influenza Among Pregnant People and Infants.

Author

Olson, Samantha M., Dawood, Fatimah S., Grohskopf, Lisa A., and Ellington, Sascha

Subjects
INFLUENZA prevention, COMMUNICABLE diseases, INFLUENZA vaccines, HOSPITAL care, INFLUENZA, PREGNANT women, ANTIVIRAL agents, COVID-19 pandemic, CHILDREN, PREGNANCY
Abstract

The landscape of research on the benefits of influenza vaccines and antivirals to protect pregnant persons and infants has increased in recent years, while influenza vaccination rates and antiviral usage have declined. Pregnant people and infants <6 months of age are at increased risk of hospitalization with influenza, making protection of this population essential. Maternal influenza vaccination at any time during pregnancy is the best way to reduce the risk of influenza and severe influenza in both pregnant people and their infants <6 months of age. Influenza antiviral medications for pregnant people and infants are also recommended as early as possible if influenza is confirmed or suspected. This report will update on the current research on the benefits of influenza vaccination during pregnancy and influenza antiviral medication for the pregnant person and infant, current Advisory Committee on Immunization Practices recommendations for influenza vaccination in pregnancy and vaccination coverage rates, current influenza antiviral medication guidance and usage rates in pregnancy and among infants, and future directions for influenza pregnancy research. With over half a century of maternal influenza vaccination in the United States, we have improved protection for pregnant persons and infants against influenza, but we still have room for improvement and optimization with new challenges to overcome following the COVID-19 pandemic. By continuing to fill research gaps and increase vaccination coverage and antiviral usage, there is potential for significant reductions in the domestic and global burden of influenza in pregnant persons and infants. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

23. Sensitivity of Pregnancy Field on the COVID-19 Case Report Form Among Pregnancies Completed Through December 31, 2020: Illinois and Tennessee

Author

Manning, Susan E., Bennett, Amanda, Ellington, Sascha, Goyal, Sonal, Harvey, Elizabeth, Sizemore, Lindsey, and Wingate, Heather

Subjects
Epidemics -- Statistics -- Tennessee -- Illinois, Pregnancy -- Statistics, Sentinel health events -- Methods, Health care industry
Abstract

Purpose The considerable volume of infections from SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), has made it challenging for health departments to collect complete data for national disease reporting. We sought to examine sensitivity of the COVID-19 case report form (CRF) pregnancy field by comparing CRF data to the gold standard of CRF data linked to birth and fetal death certificates. Description CRFs for women aged 15-44 years with laboratory-confirmed SARS-CoV-2 infection were linked to birth and fetal death certificates for pregnancies completed during January 1-December 31, 2020 in Illinois and Tennessee. Among linked records, pregnancy was considered confirmed for women with a SARS-CoV-2 specimen collection date on or prior to the delivery date. Sensitivity of the COVID-19 CRF pregnancy field was calculated by dividing the number of confirmed pregnant women with SARS-CoV-2 infection with pregnancy indicated on the CRF by the number of confirmed pregnant women with SARS-CoV-2 infection. Assessment Among 4276 (Illinois) and 2070 (Tennessee) CRFs that linked with a birth or fetal death certificate, CRF pregnancy field sensitivity was 45.3% and 42.1%, respectively. In both states, sensitivity varied significantly by maternal race/ethnicity, insurance, trimester of prenatal care entry, month of specimen collection, and trimester of specimen collection. Sensitivity also varied by maternal education in Illinois but not in Tennessee. Conclusion Sensitivity of the COVID-19 CRF pregnancy field varied by state and demographic factors. To more accurately assess outcomes for pregnant women, jurisdictions might consider utilizing additional data sources and linkages to obtain pregnancy status., Author(s): Susan E. Manning [sup.1] , Amanda Bennett [sup.1] [sup.2] , Sascha Ellington [sup.1] , Sonal Goyal [sup.1] [sup.2] , Elizabeth Harvey [sup.1] [sup.3] , Lindsey Sizemore [sup.3] , Heather [...]

Published
2022
Full Text
View/download PDF

25. Abnormal uterine bleeding diagnoses and care following COVID-19 vaccination

Author

DeNoble, Anna E., DeSilva, Malini, Ellington, Sascha, Henninger, Michelle, Jazwa, Amelia, Kharbanda, Elyse, Lipkind, Heather, Malden, Debbie, McNeil, Michael M., Tartof, Sara, Zerbo, Ousseny, Brooks, Neon, Irving, Stephanie A., Kauffman, Tia L., Vesco, Kimberly K., Slaughter, Matthew, Smith, Ning, Tepper, Naomi K., Olson, Christine K., Weintraub, Eric S., and Naleway, Allison L.

Published
2024
Full Text
View/download PDF

27. Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity — IVY Network, 26 Hospitals, October 18, 2023–March 9, 2024

Author

Ma, Kevin C., primary, Surie, Diya, additional, Lauring, Adam S., additional, Martin, Emily T., additional, Leis, Aleda M., additional, Papalambros, Leigh, additional, Gaglani, Manjusha, additional, Columbus, Christie, additional, Gottlieb, Robert L., additional, Ghamande, Shekhar, additional, Peltan, Ithan D., additional, Brown, Samuel M., additional, Ginde, Adit A., additional, Mohr, Nicholas M., additional, Gibbs, Kevin W., additional, Hager, David N., additional, Saeed, Safa, additional, Prekker, Matthew E., additional, Gong, Michelle Ng, additional, Mohamed, Amira, additional, Johnson, Nicholas J., additional, Srinivasan, Vasisht, additional, Steingrub, Jay S., additional, Khan, Akram, additional, Hough, Catherine L., additional, Duggal, Abhijit, additional, Wilson, Jennifer G., additional, Qadir, Nida, additional, Chang, Steven Y., additional, Mallow, Christopher, additional, Kwon, Jennie H., additional, Parikh, Bijal, additional, Exline, Matthew C., additional, Vaughn, Ivana A., additional, Ramesh, Mayur, additional, Safdar, Basmah, additional, Mosier, Jarrod, additional, Harris, Estelle S., additional, Shapiro, Nathan I., additional, Felzer, Jamie, additional, Zhu, Yuwei, additional, Grijalva, Carlos G., additional, Halasa, Natasha, additional, Chappell, James D., additional, Womack, Kelsey N., additional, Rhoads, Jillian P., additional, Baughman, Adrienne, additional, Swan, Sydney A., additional, Johnson, Cassandra A., additional, Rice, Todd W., additional, Casey, Jonathan D., additional, Blair, Paul W., additional, Han, Jin H., additional, Ellington, Sascha, additional, Lewis, Nathaniel M., additional, Thornburg, Natalie, additional, Paden, Clinton R., additional, Atherton, Lydia J., additional, Self, Wesley H., additional, Dawood, Fatimah S., additional, and DeCuir, Jennifer, additional

Published
2024
Full Text
View/download PDF

28. Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy — SET-NET, 16 Jurisdictions, March 29–October 14, 2020

Author

CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team, Woodworth, Kate R., Olsen, Emily O’Malley, Neelam, Varsha, Lewis, Elizabeth L., Galang, Romeo R., Oduyebo, Titilope, Aveni, Kathryn, Yazdy, Mahsa M., Harvey, Elizabeth, Longcore, Nicole D., Barton, Jerusha, Fussman, Chris, Siebman, Samantha, Lush, Mamie, Patrick, Paul H., Halai, Umme-Aiman, Valencia-Prado, Miguel, Orkis, Lauren, Sowunmi, Similoluwa, Schlosser, Levi, Khuwaja, Salma, Read, Jennifer S., Hall, Aron J., Meaney-Delman, Dana, Ellington, Sascha R., Gilboa, Suzanne M., and Tong, Van T.

Published
2020

30. Characteristics and Maternal and Birth Outcomes of Hospitalized Pregnant Women with Laboratory-Confirmed COVID-19 — COVID-NET, 13 States, March 1–August 22, 2020

Author

COVID-NET Surveillance Team, Delahoy, Miranda J., Whitaker, Michael, O’Halloran, Alissa, Chai, Shua J., Kirley, Pam Daily, Alden, Nisha, Kawasaki, Breanna, Meek, James, Yousey-Hindes, Kimberly, Anderson, Evan J., Openo, Kyle P., Monroe, Maya L., Ryan, Patricia A., Fox, Kimberly, Kim, Sue, Lynfield, Ruth, Siebman, Samantha, Davis, Sarah Shrum, Sosin, Daniel M., Barney, Grant, Muse, Alison, Bennett, Nancy M., Felsen, Christina B., Billing, Laurie M., Shiltz, Jessica, Sutton, Melissa, West, Nicole, Schaffner, William, Talbot, H. Keipp, George, Andrea, Spencer, Melanie, Ellington, Sascha, Galang, Romeo R., Gilboa, Suzanne M., Tong, Van T., Piasecki, Alexandra, Brammer, Lynnette, Fry, Alicia M., Hall, Aron J., Wortham, Jonathan M., Kim, Lindsay, and Garg, Shikha

Published
2020

32. Postmenopausal bleeding after COVID-19 vaccination

Author

Crane, Brad, Mittendorf, Kathleen F., Burch, Debra, DeSilva, Malini, Ellington, Sascha, Henninger, Michelle, Jazwa, Amelia, Kharbanda, Elyse, Lipkind, Heather, Malden, Debbie, McNeil, ; Michael M., Suh-Burgmann, Betty, Tartof, Sara, Zerbo, Ousseny, Kauffman, Tia L., Irving, Stephanie A., Brooks, Neon, Vesco, Kimberly K., Slaughter, Matthew, Smith, Ning, Tepper, Naomi K., Olson, Christine K., Weintraub, Eric S., and Naleway, Allison L.

Published
2024
Full Text
View/download PDF

33. Update : Characteristics of a Nationwide Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injury — United States, August 2019–January 2020

Author

Lung Injury Response Epidemiology/Surveillance Task Force, Krishnasamy, Vikram P., Hallowell, Benjamin D., Ko, Jean Y., Board, Amy, Hartnett, Kathleen P., Salvatore, Phillip P., Danielson, Melissa, Kite-Powell, Aaron, Twentyman, Evelyn, Kim, Lindsay, Cyrus, Alissa, Wallace, Megan, Melstrom, Paul, Haag, Brittani, King, Brian A., Briss, Peter, Jones, Christopher M., Pollack, Lori A., and Ellington, Sascha

Published
2020

34. Population-Based Surveillance for Birth Defects Potentially Related to Zika Virus Infection — 22 States and Territories, January 2016–June 2017

Author

Smoots, Ashley N., Olson, Samantha M., Cragan, Janet, Delaney, Augustina, Roth, Nicole M., Godfred-Cato, Shana, Jones, Abbey M., Nahabedian, John F., Fornoff, Jane, Sandidge, Theresa, Yazdy, Mahsa M., Higgins, Cathleen, Olney, Richard S., Eckert, Valorie, Forkner, Allison, Fox, Deborah J., Stolz, Amanda, Crawford, Katherine, Cho, Sook Ja, Knapp, Mary, Ahmed, Muhammad Farooq, Lake-Burger, Heather, Elmore, Amanda L., Langlois, Peter, Breidenbach, Rebecca, Nance, Amy, Denson, Lindsay, Caton, Lisa, Forestieri, Nina, Bergman, Kristin, Humphries, Brian K., Leedom, Vinita Oberoi, Tran, Tri, Johnston, Julie, Valencia-Prado, Miguel, Pérez-González, Stephany, Romitti, Paul A., Fall, Carrie, Bryan, J. Michael, Barton, Jerusha, Arias, William, St. John, Kristen, Mann, Sylvia, Kimura, Jonathan, Orantes, Lucia, Martin, Brennan, de Wilde, Leah, Ellis, Esther M., Song, Ziwei, Akosa, Amanda, Goodroe, Caroline, Ellington, Sascha R., Tong, Van T., Gilboa, Suzanne M., Moore, Cynthia A., and Honein, Margaret A.

Published
2020

35. Update : Product, Substance-Use, and Demographic Characteristics of Hospitalized Patients in a Nationwide Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injury — United States, August 2019–January 2020

Author

Lung Injury Response Epidemiology/Surveillance Task Force, Ellington, Sascha, Salvatore, Phillip P., Ko, Jean, Danielson, Melissa, Kim, Lindsay, Cyrus, Alissa, Wallace, Megan, Board, Amy, Krishnasamy, Vikram, King, Brian A., Rose, Dale, Jones, Christopher M., and Pollack, Lori A.

Published
2020

36. Update : Interim Guidance for Health Care Professionals Evaluating and Caring for Patients with Suspected E-cigarette, or Vaping, Product Use–Associated Lung Injury and for Reducing the Risk for Rehospitalization and Death Following Hospital Discharge — United States, December 2019

Author

Lung Injury Response Clinical Task Force, Lung Injury Response Clinical Working Group, Evans, Mary E., Twentyman, Evelyn, Click, Eleanor S., Goodman, Alyson B., Weissman, David N., Kiernan, Emily, Hocevar, Susan Adkins, Mikosz, Christina A., Danielson, Melissa, Anderson, Kayla N., Ellington, Sascha, Lozier, Matthew J., Pollack, Lori A., Rose, Dale A., Krishnasamy, Vikram, Jones, Christopher M., Briss, Peter, King, Brian A., and Wiltz, Jennifer L.

Published
2020

37. Characteristics of Patients Experiencing Rehospitalization or Death After Hospital Discharge in a Nationwide Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injury — United States, 2019

Author

Lung Injury Response Epidemiology/Surveillance Task Force, Mikosz, Christina A., Danielson, Melissa, Anderson, Kayla N., Pollack, Lori A., Currie, Dustin W., Njai, Rashid, Evans, Mary E., Goodman, Alyson B., Twentyman, Evelyn, Wiltz, Jennifer L., Rose, Dale A., Krishnasamy, Vikram, King, Brian A., Jones, Christopher M., Briss, Peter, Lozier, Matthew, and Ellington, Sascha

Published
2020

38. Evaluating Differences in Whole Blood, Serum, and Urine Screening Tests for Zika Virus, Puerto Rico, USA, 2016

Author

Rosinger, Asher Y., Olson, Samantha M., Ellington, Sascha R., Perez-Padilla, Janice, Simeone, Regina M., Pedati, Caitlin S., Schroeder, Betsy A., Santiago, Gilberto A., Medina, Freddy A., Munoz-Jordan, Jorge L., Adams, Laura E., Galang, Romeo R., Valencia-Prado, Miguel, Bakkour, Sonia, Colon, Candimar, Goodwin, Mary, Meaney-Delman, Dana, Read, Jennifer S., Petersen, Lyle R., Jamieson, Denise J., Deseda, Carmen C., Honein, Margaret A., Rivera-Garcia, Brenda, and Shapiro-Mendoza, Carrie K.

Subjects
Blood -- Medical examination, Urine -- Analysis, Nucleic acids -- Testing, Serodiagnosis -- Comparative analysis, Medical screening -- Comparative analysis -- Methods, Health
Abstract

Zika virus (ZIKV) infection during pregnancy can cause severe brain and eye malformations and is associated with neurodevelopmental abnormalities in affected infants (1). Currently, ZIKV testing with concurrent dengue virus [...]

Published
2021
Full Text
View/download PDF

41. Postmenopausal bleeding after COVID-19 vaccination

Author

Kauffman, Tia L., primary, Irving, Stephanie A., additional, Brooks, Neon, additional, Vesco, Kimberly K., additional, Slaughter, Matthew, additional, Smith, Ning, additional, Tepper, Naomi K., additional, Olson, Christine K., additional, Weintraub, Eric S., additional, Naleway, Allison L., additional, Crane, Brad, additional, Mittendorf, Kathleen F., additional, Burch, Debra, additional, DeSilva, Malini, additional, Ellington, Sascha, additional, Henninger, Michelle, additional, Jazwa, Amelia, additional, Kharbanda, Elyse, additional, Lipkind, Heather, additional, Malden, Debbie, additional, McNeil, ; Michael M., additional, Suh-Burgmann, Betty, additional, Tartof, Sara, additional, and Zerbo, Ousseny, additional

Published
2024
Full Text
View/download PDF

42. A Preparedness Model for Mother–Baby Linked Longitudinal Surveillance for Emerging Threats

Author

Woodworth, Kate R., Reynolds, Megan R., Burkel, Veronica, Gates, Cymone, Eckert, Valorie, McDermott, Catherine, Barton, Jerusha, Wilburn, Amanda, Halai, Umme-Aiman, Brown, Catherine M., Bocour, Angelica, Longcore, Nicole, Orkis, Lauren, Lopez, Camille Delgado, Sizemore, Lindsey, Ellis, Esther M., Schillie, Sarah, Gupta, Neil, Bowen, Virginia B., Torrone, Elizabeth, Ellington, Sascha R., Delaney, Augustina, Olson, Samantha M., Roth, Nicole M., Whitehill, Florence, Zambrano, Laura D., Meaney-Delman, Dana, Fehrenbach, S. Nicole, Honein, Margaret A., Tong, Van T., and Gilboa, Suzanne M.

Published
2021
Full Text
View/download PDF

43. Thiamin and Riboflavin in Human Milk: Effects of Lipid-Based Nutrient Supplementation and Stage of Lactation on Vitamer Secretion and Contributions to Total Vitamin Content.

Author

Hampel, Daniela, Shahab-Ferdows, Setareh, Adair, Linda, Bentley, Margaret, Flax, Valerie, Jamieson, Denise, Ellington, Sascha, Tegha, Gerald, Chasela, Charles, Kamwendo, Debbie, and Allen, Lindsay

Subjects
Breast Feeding, Confidence Intervals, Dietary Supplements, Female, Flavin-Adenine Dinucleotide, Humans, Lactation, Lipids, Milk, Human, Riboflavin, Thiamine, Thiamine Monophosphate, Thiamine Pyrophosphate, Vitamins
Abstract

While thiamin and riboflavin in breast milk have been analyzed for over 50 years, less attention has been given to the different forms of each vitamin. Thiamin-monophosphate (TMP) and free thiamin contribute to total thiamin content; flavin adenine-dinucleotide (FAD) and free riboflavin are the main contributors to total riboflavin. We analyzed milk collected at 2 (n = 258) or 6 (n = 104), and 24 weeks (n = 362) from HIV-infected Malawian mothers within the Breastfeeding, Antiretrovirals and Nutrition (BAN) study, randomly assigned at delivery to lipid-based nutrient supplements (LNS) or a control group, to investigate each vitamers contribution to total milk vitamin content and the effects of supplementation on the different thiamin and riboflavin vitamers at early and later stages of lactation, and obtain insight into the transport and distribution of these vitamers in human milk. Thiamin vitamers were derivatized into thiochrome-esters and analyzed by high-performance liquid-chromatography-fluorescence-detection (HPLC-FLD). Riboflavin and FAD were analyzed by ultra-performance liquid-chromatography-tandem-mass-spectrometry (ULPC-MS/MS). Thiamin-pyrophosphate (TPP), identified here for the first time in breast milk, contributed 1.9-4.5% to total thiamin. Free thiamin increased significantly from 2/6 to 24 weeks regardless of treatment indicating an active transport of this vitamer in milk. LNS significantly increased TMP and free thiamin only at 2 weeks compared to the control: median 170 versus 151 μg/L (TMP), 13.3 versus 10.5 μg/L (free thiamin, p

Published
2016

45. Possible Exposures Among Mpox Patients Without Reported Male-to-Male Sexual Contact--Six U.S. Jurisdictions, November 1-December 14, 2022

Author

Sharpe, J. Danielle, Charniga, Kelly, Byrd, Katrina M., Stefanos, Ruth, Lewis, Linda, Watson, Jessica, Feldpausch, Amanda, Pavlick, Jessica, Hand, Julie, Sokol, Theresa, Ortega, Emma, Pathela, Preeti, Hennessy, Robin R., Dulcey, Melissa, McHugh, Lisa, Pietrowski, Michael, Perella, Dana, Shah, Seema, Maroufi, Azarnoush, Taylor, Melanie, Cope, Anna, Belay, Ermias D., Ellington, Sascha, McCollum, Andrea M., Pao, Leah Zilversmit, Guagliardo, Sarah Anne J., and Dawson, Patrick

Subjects
Jurisdiction, Skin, Health
Abstract

Introduction During infectious disease outbreaks, there are often cases for which a source of infection cannot be identified. The 2022 mpox outbreak disproportionately affected adult gay, bisexual, and other men [...]

Published
2023

46. Preventing Vectorborne Transmission of Zika Virus Infection During Pregnancy, Puerto Rico, USA, 2016-2017

Author

Kortsmit, Katherine, von Essen, Beatriz Salvesen, Warner, Lee, D'Angelo, Denise V., Smith, Ruben A., Shapiro-Mendoza, Carrie K., Shulman, Holly B., Virella, Wanda Hernandez, Taraporewalla, Aspy, Harrison, Leslie, Ellington, Sascha, Barfield, Wanda D., Jamieson, Denise J., Cox, Shanna, Pazol, Karen, Diaz, Patricia Garcia, Herrera, Beatriz Rios, and Bernal, Manuel Vargas

Subjects
Vector-borne diseases -- Prevention, Disease transmission -- Prevention, Perinatal infection -- Prevention, Zika virus infection -- Prevention, Health
Abstract

During 2016-2017, Puerto Rico had active transmission of Zika virus (ZIKV). During January 27, 2016-June 10, 2017, the Puerto Rico Department of Health (PRDH) reported 40,357 confirmed cases of ZIKV [...]

Published
2020
Full Text
View/download PDF

47. Women's Awareness and Healthcare Provider Discussions about Zika Virus during Pregnancy, United States, 2016-2017

Author

Williams, Letitia, D'Angelo, Denise V., Bauman, Brenda, Dieke, Ada C., Ellington, Sascha R., Shapiro-Mendoza, Carrie K., Cox, Shanna, Hastings, Philip, Shulman, Holly, Harrison, Leslie, Kapaya, Martha, Barfield, Wanda D., Warner, Lee, and Group, PRAMS Zika State Working

Subjects
United States. Centers for Disease Control and Prevention, Travel, Birth defects, Disease transmission, Health care industry, Travelers, Disease susceptibility, Zika virus, Pregnancy, Pregnant women, Infants, Women, Mosquitoes, Infection, Health care industry, Health
Abstract

Zika virus infection (ZIKV), transmitted primarily by the Aedes aegypti and Ae. albopictus mosquitoes, is a serious threat to pregnant women because of the risk of microcephaly and other birth [...]

Published
2020
Full Text
View/download PDF

48. Progress Toward Equitable Mpox Vaccination Coverage: A Shortfall Analysis--United States, May 2022-April 2023

Author

Kota, Krishna Kiran, Chesson, Harrell, Hong, Jaeyoung, Zelaya, Carla, Spicknall, Ian H., Riser, Aspen P., Hurley, Elizabeth, Currie, Dustin W., Lash, R. Ryan, Carnes, Neal, Concepcion-Acevedo, Jeniffer, Ellington, Sascha, Belay, Ermias D., and Mermin, Jonathan

Subjects
Vaccination -- Analysis, Health
Abstract

More than 30,000 monkeypox (mpox) cases were reported in the United States during the 2022 multinational outbreak; cases disproportionately affected gay, bisexual, and other men who have sex with men [...]

Published
2023

49. Urban and Rural Mpox Incidence Among Persons Aged 15-64 Years--United States, May 10-December 31, 2022

Author

Zelaya, Carla E., Smith, Brandi P., Riser, Aspen P., Hong, Jaeyoung, Distler, Samantha, O'Connor, Siobhan, Belay, Ermias, Shoeb, Mohammad, Waltenburg, Michelle A., Negron, Maria E., and Ellington, Sascha

Subjects
Health
Abstract

During May 10-December 31, 2022, a total of 29,980 confirmed and probable ([dagger]) U.S. monkeypox (mpox) cases were reported to CDC, predominantly in cisgender adult men reporting recent same-gender sexual [...]

Published
2023

50. The CDC Domestic Mpox Response--United States, 2022-2023

Author

McQuiston, Jennifer H., Braden, Christopher R., Bowen, Michael D., McCollum, Andrea M., McDonald, Robert, Carnes, Neal, Carter, Rosalind J., Christie, Athalia, Doty, Jeffrey B., Ellington, Sascha, Fehrenbach, S. Nicole, Gundlapalli, Adi V., Hutson, Christina L., Kachur, Rachel E., Maitland, Aaron, Pearson, Christine M., Prejean, Joseph, Quilter, Laura A.S., Rao, Agam K., Yu, Yon, and Mermin, Jonathan

Subjects
United States. Food and Drug Administration, United States. Department of Health and Human Services, Social service, Zoonoses, Public health, Health, World Health Organization
Abstract

Monkeypox (mpox) is a serious viral zoonosis endemic in west and central Africa. An unprecedented global outbreak was first detected in May 2022. CDC activated its emergency outbreak response on [...]

Published
2023

Catalog

Books, media, physical & digital resources
See catalog results